Nathan P. Lawrence
Net worth: 46 $ as of 30/05/2024
Career history of Nathan P. Lawrence
Former positions of Nathan P. Lawrence
| Companies | Position | Start | End |
|---|---|---|---|
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Chief Tech/Sci/R&D Officer | - | - |
| PRESSURE BIOSCIENCES, INC. | Sales & Marketing | 31/07/2005 | - |
Training of Nathan P. Lawrence
| University of Miami | Undergraduate Degree |
| Southern Connecticut State University | Graduate Degree |
| Yale University | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
- Stock Market
- Insiders
- Nathan P. Lawrence
- Experience
